RFPL3 and lung carcinoma: Conversely, inhibition of CBP activity by its specific inhibitor C646 attenuated the acetylation level of RFPL3 (Figure 2C), suggesting that CBP mediated the tumor-specific acetylation of RFPL3 and further interacted with each other in lung cancer cells.